Home

Laurie B. Keating

CIK 1304930 · SVP and General Counsel · last filed 2008-05-15

Laurie B. Keating is a SVP and General Counsel who has filed 14 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing shows the insider disposed of $2.4M of MLNM on May 15, 2008. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. 21 SEC filings were submitted jointly with MILLENNIUM PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

14

Lifetime Open-Market Net

-$1.58M

Filer Profile

Reported Address
MILLENNIUM PHARMACEUTICALS, INC.
40 LANDSDOWNE STREET
CAMBRIDGE, MA 02139
Phone
(617) 679-7000
Related Filers
MILLENNIUM PHARMACEUTICALS INC — 21 joint filings, latest 2008-05-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted SVP and General Counsel 3,197 — — -$1.58M 14 2008-05-15

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2008-05-15 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Disp (D) −95,075 -$2.38M EDGAR
2008-05-12 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted U −3,165 -$79.1K EDGAR
2008-05-07 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Gift (G) −5,000 $0 EDGAR
2008-03-11 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Sell (S) −10,000 -$129.9K EDGAR
2008-03-04 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Sell (S) −10,315 -$143.0K EDGAR
2008-02-19 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Grant (A) +30,220 $0 EDGAR
2008-01-07 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Sell (S) −10,111 -$156.2K EDGAR
2007-12-10 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Sell (S) −1,716 -$26.0K EDGAR
2007-11-06 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Mixed — -$106.6K EDGAR
2007-03-21 MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Mixed — -$32.1K EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.